Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (141-150 of 785) with videos related to

Pageof 79
Sort By:
Kidney International|June 12, 2009
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patientsChristiane Drechsler, Vera Krane, Karl Winkler, et al.
European Journal of Clinical Investigation|January 4, 2012
Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysisKarl Winkler, Michael M Hoffmann, Vera Krane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 3, 2008
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathyJan Galle, Edzard Schwedhelm, Sabine Pinnetti, et al.
Lancet (London, England)|November 28, 2025
Chronic kidney diseaseWilliam G Herrington, Parminder K Judge, Morgan E Grams, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 2026
Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessmentHiddo J L Heerspink, Bengt Fellstrom, Christoph Wanner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 2004
Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patientsChristoph Wanner, Udo Bahner, Renate Mattern, et al.
Atherosclerosis|August 30, 2011
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D studyMichael M Hoffmann, Winfried März, Bernd Genser, et al.
Annual Review of Medicine|November 25, 2010
The Fabry cardiomyopathy: models for the cardiologistFrank Weidemann, Markus Niemann, David G Warnock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2019
Major adverse renal events (MARE): a proposal to unify renal endpointsFriedrich C Prischl, Peter Rossing, George Bakris, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 17, 2024
Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature ReviewChae Sung Lee, Yogesh Kulkarni, Vicki Pierre, et al.
Pageof 79

Showing results (141-150 of 785) with videos related to

Sort By:
Pageof 79
Kidney International|June 12, 2009
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patientsChristiane Drechsler, Vera Krane, Karl Winkler, et al.
European Journal of Clinical Investigation|January 4, 2012
Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysisKarl Winkler, Michael M Hoffmann, Vera Krane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 3, 2008
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathyJan Galle, Edzard Schwedhelm, Sabine Pinnetti, et al.
Lancet (London, England)|November 28, 2025
Chronic kidney diseaseWilliam G Herrington, Parminder K Judge, Morgan E Grams, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 2026
Reconsidering the measurement of urinary proteins in chronic kidney disease: towards a global consensus on albuminuria assessmentHiddo J L Heerspink, Bengt Fellstrom, Christoph Wanner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 2004
Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patientsChristoph Wanner, Udo Bahner, Renate Mattern, et al.
Atherosclerosis|August 30, 2011
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D studyMichael M Hoffmann, Winfried März, Bernd Genser, et al.
Annual Review of Medicine|November 25, 2010
The Fabry cardiomyopathy: models for the cardiologistFrank Weidemann, Markus Niemann, David G Warnock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2019
Major adverse renal events (MARE): a proposal to unify renal endpointsFriedrich C Prischl, Peter Rossing, George Bakris, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 17, 2024
Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature ReviewChae Sung Lee, Yogesh Kulkarni, Vicki Pierre, et al.
Pageof 79